Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest
Fig 1
Representative sigmoidal concentration-response curve of cisplatin in A549 and A549rCDDP2000 cells.
Survival is expressed in terms of % compared to untreated cells as mean ± SD.